India coronary stent market, valued at US$ 481 Mn in 2015, is expected to reach US$ 531 Mn in revenues by 2016-end, according to a new research report by Future Market Insights. The report titled, “Coronary Stent Market: India Industry Analysis and Opportunity Assessment, 2016-2026” projects the market to increase at 14% CAGR through 2026 and surpass US$ 1.8 Bn in revenues.
Demand for coronary stents is expected to be driven by government initiatives to offer better healthcare amenities. Capping of coronary stents prices, increase in geriatric population, and increasing number of PCI procedure to treat CHD are other key factors anticipated to fuel demand for coronary stents during the forecast period.
Easing of norms such as exemptions in direct taxes, while allowing 100 percent FDI in medical devices segment under the automatic route is expected to encourage entry of foreign players in the healthcare sector in the near future.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-in-1485
Increasing prevalence of diabetes is high among the ageing population in the country. In 2014, 43.2% of the sampled population in the country was aware about diabetes and related treatment options. Over the last few years, number of PCI procedures have increased in India due to increase in prevalence of CHD.
India coronary stent market is segmented on the basis of product type, raw material and end-use.
On the basis of product type, the market has been segmented into Drug Eluting Stent (DES), Bare Metal Stent (BMS) and Bioresorbable Vascular Stent (BVS). Drug Eluting Stent segment is expected to register impressive CAGR of 14.0% during the forecast period.
On the basis of raw material, the market is segmented into cobalt-chromium, stainless steel, platinum-chromium, nickel-titanium and polymer. Currently, demand for cobalt-chromium is the highest, followed by platinum-chromium.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-in-1485
On the basis of end use, India coronary stents market is segmented into hospitals, ambulatory surgical centres and cardiac catheterization laboratories. By end use, hospitals segment is expected to witness fastest growth during the forecast period.
The key players profiled in FMI’s report include Abbott Laboratories, Medtronic, Inc., Biosensors Inc., and Boston Scientific Inc. The report also identifies company-specific strategies related to product development, market consolidation initiatives and analysis of their specific strengths, weaknesses, opportunities and threats.
Query Discussion With Analyst@ http://www.futuremarketinsights.com/askus/rep-in-1485